Browse Prior Art Database

Orodispersible pharmaceutical formulaions for antipsychotic agent

IP.com Disclosure Number: IPCOM000011779D
Publication Date: 2003-Mar-14
Document File: 1 page(s) / 50K

Publishing Venue

The IP.com Prior Art Database

This text was extracted from a Microsoft Word document.
At least one non-text object (such as an image or picture) has been suppressed.
This is the abbreviated version, containing approximately 100% of the total text.

Orodispersible Pharmaceutical Formulations for Antipsychotic Agent

Solid orodispersible dosage form capable of releasing 1mg to 10 mg of the active pharmaceutical ingredient represented by the chemical formula shown in Figure 1, optionally in the form of its salts or hydrates, to human patients following administration by disintegrating in the oral cavity may contain 0.1% to 5% of the active pharmaceutical ingredient represented by the chemical formula shown in Figure 1, optionally in the form of its salts or hydrates, 35% to 55% of a sugar-type diluent, 1% to 4% of a naturally occurring clathrate e.g. betadex, 30% to 50% of a diluent selected from microcrystalline celluloses, 0.1% to 2% of an internally cross-linked sodium carboxy methylcellulose disintegrant and optionally other conventional tabletting excipients selected from known lubricants, sweeteners, opacifiers, glidants and/or anti-caking agents in amounts from 0.1% to 2%, said dosage form being prepared by combining complexed active ingredient, with mixed diluents, granulating and compressing lubricated granules to a hardness of 3 to 4 kg/cm2.

N

 
Figure 1

                   
     
   
 
   

CH3

 
     
     
 
 
 

Anonymous